The Bleeding With Antithrombotic Therapy Study 2
The Bleeding With Antithrombotic Therapy Study 2
The purpose of this study is to determine the incidence and severity of bleeding
 complications in patients with cerebrovascular and cardiovascular diseases treated with oral
 antithrombotic therapy.
Inclusion Criteria:

 -  Patients with cerebrovascular or cardiovascular diseases who start or continue taking
 oral antithrombotics (antiplatelets and/or anticoagulants) to prevent vascular events

 -  Patients who are able to receive MRI

 -  Provision of written informed consent either directly or by a suitable surrogate

 Exclusion Criteria:

 -  MRI contraindication

 -  Any condition that in the opinion of the responsible physician or investigator that
 renders the patient unsuitable for the study